Surgical and oncological score to estimate the survival benefit of resection and chemoradiotherapy in elderly (≥70 years) glioblastoma patients: a preliminary analysis

MLA

M. Zorman, et al. “Surgical and Oncological Score to Estimate the Survival Benefit of Resection and Chemoradiotherapy in Elderly (≥70 Years) Glioblastoma Patients: A Preliminary Analysis.” Brain and Spine, vol. 2, no. 101491-, Jan. 2022. EBSCOhost, https://doi.org/10.1016/j.bas.2022.101491.

APA

M. Zorman, P. Webb, M. Nixon, S. Sravanam, S. Honeyman, M. Nandhabalan, V. Apostolopoulos, R. Stacey, C. Hobbs, & P. Plaha. (2022). Surgical and oncological score to estimate the survival benefit of resection and chemoradiotherapy in elderly (≥70 years) glioblastoma patients: a preliminary analysis. Brain and Spine, 2(101491-). https://doi.org/10.1016/j.bas.2022.101491

Chicago

M. Zorman, P. Webb, M. Nixon, S. Sravanam, S. Honeyman, M. Nandhabalan, V. Apostolopoulos, R. Stacey, C. Hobbs, and P. Plaha. 2022. “Surgical and Oncological Score to Estimate the Survival Benefit of Resection and Chemoradiotherapy in Elderly (≥70 Years) Glioblastoma Patients: A Preliminary Analysis.” Brain and Spine 2 (101491-). doi:10.1016/j.bas.2022.101491.